» Articles » PMID: 33851161

Inhibition of SARS-CoV-2 Polymerase by Nucleotide Analogs: a Single Molecule Perspective

Abstract

Teaser: We revise Remdesivir's mechanism of action and reveal SARS-CoV-2 ability to evade interferon-induced antiviral ddhCTP.

References
1.
Seifert M, van Nies P, Papini F, Arnold J, Poranen M, Cameron C . Temperature controlled high-throughput magnetic tweezers show striking difference in activation energies of replicating viral RNA-dependent RNA polymerases. Nucleic Acids Res. 2020; 48(10):5591-5602. PMC: 7261197. DOI: 10.1093/nar/gkaa233. View

2.
Dangerfield T, Huang N, Johnson K . Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase. iScience. 2020; 23(12):101849. PMC: 7695572. DOI: 10.1016/j.isci.2020.101849. View

3.
Arnold J, Sharma S, Feng J, Ray A, Smidansky E, Kireeva M . Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. PLoS Pathog. 2012; 8(11):e1003030. PMC: 3499576. DOI: 10.1371/journal.ppat.1003030. View

4.
Bera S, Seifert M, Kirchdoerfer R, van Nies P, Wubulikasimu Y, Quack S . The nucleotide addition cycle of the SARS-CoV-2 polymerase. Cell Rep. 2021; 36(9):109650. PMC: 8367775. DOI: 10.1016/j.celrep.2021.109650. View

5.
Ferron F, Subissi L, Silveira De Morais A, Le N, Sevajol M, Gluais L . Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA. Proc Natl Acad Sci U S A. 2017; 115(2):E162-E171. PMC: 5777078. DOI: 10.1073/pnas.1718806115. View